Advertisement
Advertisement

IBRX

IBRX logo

ImmunityBio, Inc. Common Stock

7.29
USD
Sponsored
-0.20
-2.61%
Apr 10, 15:59 UTC -4
Closed
exchange

After-Market

7.28

-0.01
-0.14%

ImmunityBio, Inc. Common Stock Profile

About

ImmunityBio Inc. is a late-clinical-stage immunotherapy company developing therapies which drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems. ImmunityBio Inc., formerly known as NantKwest Inc., is based in CULVER CITY, Calif.

Info & Links

CEO

Richard Adcock

Headquarters

3530 JOHN HOPKINS COURT
SAN DIEGO, CA 92121, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.immunitybio.com

Auditor

Ernst & Young LLP

Share holders

67

Employees

691

ImmunityBio, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

7.51B

Enterprise Value

7.90B

Enterprise Value/EBITDA(ttm)

-32.86

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

67.88

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

99.40%

Operating Margin(ttm)

-310.18%

Profit Margin(ttm)

-376.69%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

816.05%

Return on Assets(ttm)

-81.40%

Income Statement

Revenue(ttm)

113.29M

Revenue Per Share(ttm)

0.11

Gross Profit(ttm)

112.54M

EBITDA(ttm)3

-240.50M

Net Income Available to Common(ttm)

-351.40M

Diluted EPS(ttm)

-0.38

Share Statistics

Beta (5Y Monthly)

0.13

52-Week Change

177.00%

S&P 500 52-Week Change

26.10%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

1.03B

Dividend Yield

0.00%

Float4

313.78M

% Held by Insiders

69.48%

% Held by Institutions

8.58%

Balance Sheet

Total Cash(mrq)

242.82M

Total Cash Per Share(mrq)

0.24

Total Debt(mrq)

477.09M

Total Debt/Equity(mrq)

-95.50%

Current Ratio(mrq)

5.10%

Quick Ratio(mrq)

5.08%

Book Value Per Share(mrq)

-0.49

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.33

Free Cash Flow(ytd)

-308.78M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement